Search
Search
About
Log in
Join
Experiences with
Zepzelca
Posts
Communities
1 public post
Filter results
FDA approves Zepzelca (lurbinectedin) for treatment of advanced SCLC that has progressed after platinum chemotherapy
On June 15, 2020, the Food and Drug Administration (FDA) approved
Zepzelca
(lurbinectedin) for treatment of advanced small cell lung cancer (SCLC) whose cancer has progressed after platinum chemotherapy.
On June 15, 2020, the Food and Drug Administration (FDA) approved
Zepzelca
(lurbinectedin) for treatment of advanced small cell lung cancer (SCLC) whose cancer has progressed after platinum chemotherapy.
Miranda_GO2
Partner
in
Lung Cancer Support
4 years ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
Filter results
Clear filters
Posted in
All communities
Lung Cancer Support
1 result
Sort by
Most Relevant
Newest